| 1 | CCL5, CCR5
|
| Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
|
| Aldinucci D, Casagrande N.
|
| Int J Mol Sci. May 16;19(5):1477. doi: 10.3390/ijms19051477 2018
|
| 2 | CCL5, CCR5
|
| CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells.
|
| Singh SK, Mishra MK, Eltoum IA, Bae S, Lillard JW Jr, Singh R.
|
| Sci Rep. Jan 22;8(1):1323. doi: 10.1038/s41598-018-19643-0 2018
|
| 3 | CCL3, CCL5
|
| Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3.
|
| Liang WG, Triandafillou CG, Huang TY, Zulueta MM, Banerjee S, Dinner AR, Hung SC, Tang WJ.
|
| Proc Natl Acad Sci U S A 113(18):5000-5. doi: 10.1073/pnas.1523981113. Epub 2016 Apr 18.
2016
|
| 4 | CCL5, ETS1, FLI1
|
| The Fli-1 transcription factor regulates the expression of CCL5/RANTES.
|
| Lennard Richard ML, Sato S, Suzuki E, Williams S, Nowling TK, Zhang XK.
|
| J Immunol 193(6):2661-8. doi: 10.4049/jimmunol.1302779. Epub 2014 Aug 6.
2014
|
| 5 | CCL5, IL15, IL15RA, NFKB1
|
| IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
|
| Chenoweth MJ, Mian MF, Barra NG, Alain T, Sonenberg N, Bramson J, Lichty BD, Richards CD, Ma A, Ashkar AA.
|
| J Immunol 188(9):4149-57. doi: 10.4049/jimmunol.1101883. Epub 2012 Mar 23.
2012
|
| 6 | CCL5, KLF13
|
| Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes.
|
| Kim DS, Zhang W, Millman SE, Hwang BJ, Kwon SJ, Clayberger C, Pagano M, Krensky AM.
|
| Blood 120(8):1658-67. doi: 10.1182/blood-2012-03-415968. Epub 2012 Jul 13.
2012
|
| 7 | CCL5, MTOR
|
| The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis.
|
| Chan O, Burke JD, Gao DF, Fish EN.
|
| J Biol Chem 287(35):29406-16. doi: 10.1074/jbc.M112.348946. Epub 2012 Jul 10. 2012
|
| 8 | CCL5, GLI2, IL6
|
| GLI2 transcription factor mediates cytokine cross-talk in the tumor microenvironment.
|
| Elsawa SF, Almada LL, Ziesmer SC, Novak AJ, Witzig TE, Ansell SM, Fernandez-Zapico ME.
|
| J Biol Chem 286(24):21524-34. Epub 2011 Mar 18.
2011
|
| 9 | CCL5
|
| A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection.
|
| Crawford A, Angelosanto JM, Nadwodny KL, Blackburn SD, Wherry EJ.
|
| PLoS Pathog 7(7):e1002098. Epub 2011 Jul 21.
2011
|
| 10 | CCL5
|
| CCL5 (RANTES) gene polymorphisms in pulmonary tuberculosis patients of south India.
|
| Selvaraj P, Alagarasu K, Singh B, Afsal K.
|
| Int J Immunogenet 38(5):397-402. doi: 10.1111/j.1744-313X.2011.01021.x. Epub 2011 Jun 27.
2011
|
| 11 | CCL5, CCR7
|
| Significantly increased CCL5/RANTES and CCR7 mRNA levels in localized scleroderma.
|
| Gambichler T, Skrygan M, Labanski AA, Kolios AG, Altmeyer P, Kreuter A.
|
| Regul Pept 170(1-3):4-6. Epub 2011 May 25.
2011
|
| 12 | CCL5
|
| Polymorphisms in the RANTES gene increase susceptibility to active tuberculosis in Tunisia.
|
| Ben-Selma W, Harizi H, Bougmiza I, Ben Kahla I, Letaief M, Boukadida J.
|
| DNA Cell Biol 30(10):789-800. Epub 2011 Apr 21.
2011
|
| 13 | CCL5
|
| Polymorphism in the promoter of the CCL5 gene (CCL5G-403A) in a cohort of North Indian children with Kawasaki disease. A preliminary study.
|
| Chaudhuri K, Singh Ahluwalia T, Singh S, Binepal G, Khullar M.
|
| Clin Exp Rheumatol 29(1 Suppl 64):S126-30. Epub 2011 May 11.
2011
|
| 14 | CCL5, IL13
|
| Induction of IL-13 production and upregulated expression of protease activated receptor-1 by RANTES in a mast cell line.
|
| Zhang H, Yang H, Ma W, He S.
|
| Cytokine 53(2):231-8. Epub 2010 Nov 11.
2011
|
| 15 | CCL5
|
| Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity.
|
| Elsawa SF, Novak AJ, Ziesmer SC, Almada LL, Hodge LS, Grote DM, Witzig TE, Fernandez-Zapico ME, Ansell SM.
|
| Blood 118(20):5540-9. doi: 10.1182/blood-2011-04-351742. Epub 2011 Sep 14.
2011
|
| 16 | CCL2, CCL3, CCL4, CCL5
|
| Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.
|
| Neumeier M, Bauer S, Brühl H, Eisinger K, Kopp A, Abke S, Walter R, Schäffler A, Buechler C.
|
| Cytokine 56(3):573-80. doi: 10.1016/j.cyto.2011.08.017. Epub 2011 Sep 3. Erratum in: Cytokine. 2013 Jun;62(3):453.
2011
|
| 17 | CCL5, CCR5
|
| Resequencing of the CCL5 and CCR5 genes and investigation of variants for association with diabetic nephropathy.
|
| Pettigrew KA, McKnight AJ, Patterson CC, Kilner J, Sadlier DM, Maxwell AP.
|
| J Hum Genet 55(4):248-51. Epub 2010 Mar 5.
2010
|
| 18 | CCL5
|
| Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer.
|
| Weng CJ, Chien MH, Lin CW, Chung TT, Zavras AI, Tsai CM, Chen MK, Yang SF.
|
| Oral Oncol 46(10):767-72. Epub 2010 Aug 21.
2010
|
| 19 | CCL5
|
| CCL5 promotes macrophage recruitment and survival in human adipose tissue.
|
| Keophiphath M, Rouault C, Divoux A, Clément K, Lacasa D.
|
| Arterioscler Thromb Vasc Biol 30(1):39-45. Epub 2009 Nov 5.
2010
|
| 20 | CCL5
|
| CCL5 participates in early protection against Mycobacterium tuberculosis.
|
| Vesosky B, Rottinghaus EK, Stromberg P, Turner J, Beamer G.
|
| J Leukoc Biol 87(6):1153-65. Epub 2010 Apr 6.
2010
|
| 21 | CCL5
|
| Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice.
|
| Berres ML, Koenen RR, Rueland A, Zaldivar MM, Heinrichs D, Sahin H, Schmitz P, Streetz KL, Berg T, Gassler N, Weiskirchen R, Proudfoot A, Weber C, Trautwein C, Wasmuth HE.
|
| J Clin Invest 120(11):4129-40. doi: 10.1172/JCI41732. Epub 2010 Oct 18.
2010
|
| 22 | CCL5
|
| Tissue resident stem cells produce CCL5 under the influence of cancer cells and thereby promote breast cancer cell invasion.
|
| Pinilla S, Alt E, Abdul Khalek FJ, Jotzu C, Muehlberg F, Beckmann C, Song YH.
|
| Cancer Lett 284(1):80-5. Epub 2009 May 7.
2009
|
| 23 | CCL5
|
| Expression of CC chemokine ligand 5 in patients with rheumatoid arthritis and its correlation with disease activity and medication.
|
| Yang MH, Wu FX, Xie CM, Qing YF, Wang GR, Guo XL, Tang Z, Zhou JG, Yuan GH.
|
| Chin Med Sci J 24(1):50-4.
2009
|
| 24 | CCL5, CCR5
|
| CCL5/CCR5 axis promotes the motility of human oral cancer cells.
|
| Chuang JY, Yang WH, Chen HT, Huang CY, Tan TW, Lin YT, Hsu CJ, Fong YC, Tang CH.
|
| J Cell Physiol 220(2):418-26.
2009
|
| 25 | CCL5
|
| Functional SNPs of the CCL5 gene and non-emphysematous phenotype in patients with COPD.
|
| Hizawa N, Makita H, Nasuhara Y, Hasegawa M, Nagai K, Ito Y, Betsuyaku T, Konno S, Nishimura M; the Hokkaido COPD Cohort Study Group.
|
| Eur Respir J ur Respir J. 2008 Apr 2. [Epub ahead of print] 2008
|
| 26 | PRPF4, CCL5, KLF13
|
| Interaction of PRP4 with Kruppel-like factor 13 regulates CCL5 transcription.
|
| Huang B, Ahn YT, McPherson L, Clayberger C, Krensky AM.
|
| J Immunol 178(11):7081-7. 2007
|
| 27 | CCR5, CCL5
|
| CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection.
|
| Tyner JW, Uchida O, Kajiwara N, Kim EY, Patel AC, O'sullivan MP, Walter MJ, Schwendener RA, Cook DN, Danoff TM, Holtzman MJ.
|
| Nat Med 11(11):1180-7. Epub 2005 Oct 2. 2005
|
| 28 | CCL5
|
| Modulating influence on HIV/AIDS by interacting RANTES gene variants.
|
| An P, Nelson GW, Wang L, Donfield S, Goedert JJ, Phair J, Vlahov D, Buchbinder S, Farrar WL, Modi W, O'Brien SJ, Winkler CA.
|
| Proc Natl Acad Sci U S A 99(15):10002-7. 2002
|
| 29 | CCL5, KLK13
|
| A translational rheostat for RFLAT-1 regulates RANTES expression in T lymphocytes.
|
| Nikolcheva T, Pyronnet S, Chou SY, Sonenberg N, Song A, Clayberger C, Krensky AM.
|
| J Clin Invest 110(1):119-26. 2002
|
| 30 | CCL5
|
| Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes.
|
| Locati M, Deuschle U, Massardi ML, Martinez FO, Sironi M, Sozzani S, Bartfai T, Mantovani A.
|
| J Immunol 168(7):3557-62. 2002
|
| 31 | CCL5
|
| Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression.
|
| Liu H, et al.
|
| Proc Natl Acad Sci U S A 96(8):4581-5. 1999
|
| 32 | CCL3, CCL4, CCL4L1, CCL5, CCL7, CCL11, CCL13, CCL20, CXCL12
|
| Chemokines--chemotactic cytokines that mediate inflammation.
|
| Luster AD.
|
| N Engl J Med 338(7):436-45. Review. No abstract available. 1998
|
| 33 | CCL5, TCSPL
|
| Localization of a human T-cell-specific gene, RANTES (D17S136E), to chromosome 17q11.2-q12.
|
| Donlon TA, et al.
|
| Genomics 6 : 548-553. 1990
|
| 34 | CCL5
|
| Localization of a T cell-specific cDNA, p228, to 17q11-q21.
|
| Donlon TA, et al.
|
| (HGM10) Cytogenet Cell Genet 51 : 992. 1989
|
| 35 | TCSPL, CCL5
|
| A human T cell-specific molecule is a member of a new gene family.
|
| Schall TJ, et al.
|
| J Immunol 141 : 1018-1025. 1988
|